MDD & Patient Engagement Guidelines

Summary

Join Dr. Adam Meadows for a comprehensive on-demand teaching session titled "What's Left Behind: Residual Symptoms and Effects Experienced by Patients with Major Depressive Disorder". The session will delve into the lingering symptoms of MDD that aren't generally addressed by conventional medication, including cognitive impairment, emotional blunting, and difficulty completing tasks. Discover the strain depression can put on interpersonal relationships, performance at work or school, and the development of unhealthy habits or addictions. You'll also get insights from real case studies like "Mary", a 27-year-old patient, and learn about successful treatment plans and strategies. This session aims to empower you to identify, understand and creatively address these residual symptoms to provide the most comprehensive care for your patients with MDD.

Generated by MedBot

Description

This program is funded by an independent grant from Takeda. This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.

This accredited CME online course is designed for psychiatrists and healthcare professionals to learn the latest updates in Major Depressive Disorder (MDD).

Evidence-based strategies to optimize treatment outcomes for MDD patients

Participants will learn to integrate cutting-edge clinical guidelines and research findings into individualized treatment plans, ensuring optimal patient outcomes. The course covers the application of combination therapies and adjunctive treatments tailored to patient responses and tolerances. Psychiatrists and Healthcare professionals will gain expertise in identifying and managing treatment-resistant aspects of MDD.

Address residual symptoms in MDD

Addressing residual symptoms in MDD is crucial for improving patient quality of life. This course will teach participants to identify and manage symptoms such as cognitive impairment and emotional blunting, incorporating both pharmacological and non-pharmacological approaches.

Patient engagement and education in the management of MDD

Finally, the course emphasizes the importance of patient engagement and education. Participants will learn to communicate effectively, empowering patients to take an active role in their treatment, and develop strategies to improve adherence and self-management across diverse populations.

Who is this course for

This online education program has been designed solely for healthcare professionals in the USA. The course provides continuing education for:

✅ Psychiatrists

✅ Psychiatry Physician Assistants

✅ Psychiatric Nurse Practitioners

✅ Clinical Psychologists

✅ Neurologists

✅ Family Physicians

✅ Physicians

✅ Physician Assistants

✅ Nurse Practitioners

✅ Other Health Professionals

Faculty

Dr Sagar Parikh

Dr. Sagar V. Parikh, MD, FRCPC, is an expert in depression and clinical neuroscience, currently holding the John F. Greden Professorship at the University of Michigan. He also serves as an adjunct Professor of Psychiatry at the University of Toronto. He started his medical career as a primary care physician before completing his Psychiatry residency at the University of Michigan and the University of Toronto. Dr. Parikh's extensive research interests include clinical trials, psychopharmacology, psychotherapy for mood disorders, medical education, epidemiology, biomarkers, interventional psychiatry, and health services. He has co-authored all ten editions of the CANMAT guidelines for depression and bipolar disorder and has published over 200 peer-reviewed articles. A renowned CME presenter and researcher, Dr. Parikh has earned numerous awards for his research and teaching at local, national, and international levels.

Dr Glenda Wrenn Gordon

Dr Glenda Wrenn Gordon is an Associate Professor of Clinical Psychiatry at Morehouse School of Medicine, Medical Director of Clinical Integration at Mindoula, and a member of the NAMI Board of Directors. She is a board-certified adult psychiatrist and a leader in advancing mental health equity. She was the founding director of the Kennedy Satcher Center for Mental Health Equity and has authored numerous publications, including recent work on racial disparities in depression treatment. In 2020, she received the NAMI Psychiatrist of the Year Award.

Dr Adam Meadows

Dr. Adam Meadows is a board-certified psychiatrist with expertise in mood disorders, adult ADHD, and mental health issues. He is Medical Director of Admissions and Adjunct Assistant Professor at Emory University School of Medicine. Dr. Meadows is a member of the American Psychiatric Association and the Georgia Psychiatric Physicians Association. Dr. Meadows completed his psychiatry residency at the University of Pennsylvania, serving as chief resident in his final year. He focuses on leadership development, public speaking, and reducing mental health stigma, aiming to make a positive societal impact.

Faculty, planners, and staff disclosure information

Sagar Parikh has consulted for Sage, Otsuka, and Aifred (software). He has received clinical trial contracts from Sage, Janssen, Compass and Aifred (software). Glenda Wrenn Gordon, Adam Meadows & Jade Brown have no relevant financial or non-financial interests to disclose.

Current Concepts Institute/MedAll staff and the planners and reviewers of this educational activity have no relevant financial or non-financial interests to disclose.

Unapproved and/or off-label use disclosure

Current Concepts Institute/MedAll requires CE faculty to disclose to the participants:

1. When products or procedures being discussed are off-label, unlabelled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and

2. Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.

Learning objectives

By the end of the session, participants will be able to identify the common residual symptoms and effects experienced by patients with Major Depressive Disorder (MDD) even after medication interventions.
Participants will learn to diagnose the cognitive and emotional impairments in patients with MDD that often persist despite medication treatment and can lead to difficulties in completing tasks or maintaining healthful habits.
Participants will gain insight into the strain on interpersonal relationships, performance at work or school, and other real-life consequences of depression, broadening their understanding of the holistic impact of MDD.
Participants will be able to examine and discuss treatment approaches for MDD, including the use of medical interventions, psychological testing, transcranial magnetic stimulation, family therapy, and wellness plans.
Participants will understand the importance of additional support measures, such as vocational counseling, couples therapy, academic accommodations, and community support, in enhancing the mental well-being of patients with MDD, thereby enabling them to return to a more normal, functional lifestyle.

Generated by MedBot

Similar communities

View all

Similar events and on demand videos

Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

Adam Meadows, MD What’s left behind… Residual symptoms and effects experienced by patients with Major Depressive DisorderSymptoms of MDD that medications address • Sadness • Crying spells • Low energy • Appetite changes • Sleep quality • Suicidal thoughts • Ability to experience pleasureSymptoms of MDD that may remain • Cognitive impairment • Trouble concentrating • Delayed processing • Indecisiveness • Emotional blunting • Difficulty with task completion • Low self-confidence • Unhealthy habits or addictions • Hygiene and ADL’s • Food, Substances • Consequences of financial decisionsOther consequences of depression • Strain on interpersonal relationships • Feelings of frustration or resentment • Social isolation • Caregiver burnout • Performance at work or school • Behind on assignments • Disconnection from colleagues or classmates • Missed opportunities for progress or promotionCase Patient history “Mary” • 27 y/o female • Google employee (on disability) • Recent ending of long-term relationship • Diagnoses: MDD, BPD, PTSD, OCD • Chronic SI and self-harm behavior • Severe emotional dysregulation and cognitive rigidity • Prior treatment: multiple med trials, ECTCase Treatment Plan • Medication changes • Psychological testing • Confirmed traits of Autism Spectrum • Transcranial magnetic stimulation • Family therapy • Wellness plan (i.e. behavioral contract) • Vocational counseling • Collaborated with patient’s disability attorneyCase Treatment Response • Improvement in depression symptoms • More effective communication with parents • Completed sale of home with ex-fiancé • Moved from supportive housing to independent apartment • Returned to work with accommodations • Participated actively in alumni programTreatment approaches to address residual symptoms • Marriage and/or Couples Therapy • Academic accommodations • Career coaching • Community support and engagement • Social groups (including online platforms) • Team sports / Fitness classes • Spiritual or religious organizationsThank you